Multiplexed longitudinal analysis of the cellular and microbial dynamics of acute polymicrobial sepsis in mice

Tori E Peacock1, Kenny Johnson1, Abhinav R Cheedipudi1

  • 1Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.

Frontiers in Immunology
|December 19, 2025
PubMed
Abstract

Insights

This study presents a new method for analyzing acute polymicrobial sepsis in mice. It tracks immune responses and bacterial changes, offering a more detailed understanding of sepsis progression and potential biomarkers.

Area of Science:

  • * Immunology
  • * Microbiology
  • * Animal models

Background:

  • * Acute polymicrobial sepsis is a life-threatening condition requiring early detection and management.
  • * Global health initiatives focus on sepsis due to its links to hospital readmissions and long-term health issues.
  • * Animal models are crucial for dissecting sepsis pathogenesis during its acute phase.

Purpose of the Study:

  • * To demonstrate the feasibility of multiplexed, longitudinal assessment of acute sepsis pathogenesis.
  • * To highlight the detailed insights obtainable through this advanced study method.
  • * To characterize hematological, immunological, and microbiological aspects of sepsis induction in a mouse model.

Main Methods:

  • * Utilized the fecal suspension test (FST) model in C57BL/6 mice.
  • * Employed high-dimensional flow cytometry and plasma cytokine measurements.
  • * Incorporated 16S rRNA gene sequencing for blood microbiome analysis.

Main Results:

  • * Observed a dynamic shift from pro-inflammatory to anti-inflammatory immune responses, involving myeloid-derived suppressor-like cells.
  • * Identified outgrowth of *Enterococcus* and *Staphylococcus* as causative agents in polymicrobial sepsis.
  • * Stratified septic mice into survivors and non-survivors, identifying potential pre-septic biomarkers for sepsis risk.

Conclusions:

  • * The described approach reduces animal use and enhances scientific rigor.
  • * Provides a preclinical platform for biomarker discovery and therapeutic intervention studies.
  • * Advances the study of the acute phase of sepsis, which is challenging to investigate prospectively in humans.

Related Concept Videos